Phani Sekhar of Karvy Stock Broking feels that FMCG and pharma space continue to outperform.
Phani Sekhar of Karvy Stock Broking told CNBC-TV18, "From the sector perspective nothing has been extraordinary at least in the midcap segment. There has been a lot of misses in the IT space, to some extent in infra space whatever fewer companies have reported. Other than that the most consistent results from the midcap segment have been on the FMCG side or on the pharma side."
"FMCG and pharma are the two sectors that I believe over the near to medium-term despite being reasonably owned by people and having premium valuations would still continue to outperform. If you are focusing on midcaps those are the two space that you should keep an eye out for," he added.Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.